Medtronic projects 6.75%-7.25% FY 2027 organic revenue growth while outlining $5.90-$6.00 EPS amid $250M tariff impact

EarningsNeutral

AI Analysis

Medtronic projects FY 2027 organic revenue growth of 6.75%-7.25% with EPS guidance of $5.90-$6.00, while noting a $250M negative impact from tariffs.

Revenue

6.75%-7.25% organic growth

EPS

$5.90-$6.00

Guidance

FY 2027 organic revenue growth of 6.75%-7.25% with EPS guidance of $5.90-$6.00; $250M tariff impact noted

Importance:5/10

Sentiment:

-0.15

guidanceearningstariffsFY2027

Related Companies

Read the original article

Published by Seeking Alpha Healthcare on June 3, 2026 7:32 PM